Anders D. Hove

Anders D. Hove has filed trades across 5 companies (mainly through SEC (Form 4)), most often in Anacor Pharmaceuticals, Inc., Trubion Pharmaceuticals, Inc and Alimera Sciences Inc. Over a trading history stretching from 23 October 2006 to 24 June 2016, the count stands at 58 filings.

Market trades split into 7 purchases (€11.0M) and 24 sales (€168.8M). Sales outweigh purchases by €157.8M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 2 share grants. In 2016 alone, the filings show no purchases and 11 sales.

A typical purchase (the median) is worth €1.4M.

The record was last updated on 24 June 2016 with a transaction (€3.0M) in Anacor Pharmaceuticals, Inc. The last insider purchase was made public on 8 October 2015, 4,033 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.